» Articles » PMID: 26622398

Association Between Mobilization of Circulating Endothelial Progenitor Cells and Time or Degree of Injury from Angioplasty in Patients with Exertional Angina: A Prospective Study

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2015 Dec 2
PMID 26622398
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to investigate the effect of coronary artery angioplasty on the recruitment of circulating endothelial progenitor cells (EPCs) in patients with angina pectoris. A total of 66 patients treated by coronary stenting were enrolled in the PCI group and 17 patients that underwent angiography alone were enrolled in the control group. The EPC count in the blood was measured by flow cytometry prior to and at 1, 3, 5, 7 and 24 h following angioplasty in the percutaneous coronary intervention (PCI) group, and at three time-points following angiography in the control group. Differences between the two groups included the characteristics of the coronary artery lesions, the incidence of diabetes and family history of coronary heart disease. The mean surface area of the stent deployed was 335.59±234.99 mm. No significant change in EPC count was measured in the control group. In the PCI group, a moderate and delayed increase in the number of cluster of differentiation (CD)34/kinase domain receptor (KDR) EPCs occurred at 24 h post-balloon inflation compared with the baseline level. The CD133/CD34/KDR subpopulations showed undulating changes at 3, 7 and 24 h post-PCI (P=0.016, P=0.01 and P=0.032, respectively). An arch shape was displayed in CD133/KDR cells; initially, a reduction occurred at 3 h and was maintained constantly until 7 h (P=0.003, P=0.013 and P=0.033 at 3, 5 and 7 h, respectively), after which a slight increase to the baseline level occurred at 24 h (P=0.084). The CD133/CD34 cells increased in stepwise manner until 24 h. The CD34/KDR EPC change magnitude correlated significantly with a global damage index by partial correlation analysis (P<0.001). The results suggested that a time-dependent mobilization of EPCs may be initiated by PCI; the change magnitude of the CD34/KDR cells was associated particularly with endothelial injury degree from the PCI procedure.

Citing Articles

Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary....

Yin Z, Li Z, Zhang W, Zhang S, Sui Y, Xu Y Heliyon. 2023; 9(11):e22222.

PMID: 38045163 PMC: 10689873. DOI: 10.1016/j.heliyon.2023.e22222.


Microarray meta-analysis reveals IL6 and p38β/MAPK11 as potential targets of hsa-miR-124 in endothelial progenitor cells: Implications for stent re-endothelization in diabetic patients.

Arencibia A, Salazar L Front Cardiovasc Med. 2022; 9:964721.

PMID: 36176980 PMC: 9513120. DOI: 10.3389/fcvm.2022.964721.


Endothelial Progenitor Cells in Coronary Artery Disease: From Bench to Bedside.

Pelliccia F, Zimarino M, De Luca G, Viceconte N, Tanzilli G, De Caterina R Stem Cells Transl Med. 2022; 11(5):451-460.

PMID: 35365823 PMC: 9154346. DOI: 10.1093/stcltm/szac010.


Effects of Shen-Yuan-Dan on Periprocedural Myocardial Injury and the Number of Peripheral Blood Endothelial Progenitor Cells in Patients with Unstable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention.

Zhang Z, Xing W, Liu H, Zhou Q, Liu X, Shang J Evid Based Complement Alternat Med. 2022; 2022:9055585.

PMID: 35035512 PMC: 8759927. DOI: 10.1155/2022/9055585.


The Combined Contribution of Vascular Endothelial Cell Migration and Adhesion to Stent Re-endothelialization.

Wang X, Fang F, Ni Y, Yu H, Ma J, Deng L Front Cell Dev Biol. 2021; 9:641382.

PMID: 33748131 PMC: 7969796. DOI: 10.3389/fcell.2021.641382.


References
1.
Handgretinger R, Gordon P, Leimig T, Chen X, Buhring H, Niethammer D . Biology and plasticity of CD133+ hematopoietic stem cells. Ann N Y Acad Sci. 2003; 996:141-51. DOI: 10.1111/j.1749-6632.2003.tb03242.x. View

2.
Wojakowski W, Pyrlik A, Krol M, Buszman P, Ochala A, Milewski K . Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial). Minerva Cardioangiol. 2013; 61(3):301-11. View

3.
Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher A . Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001; 103(24):2885-90. DOI: 10.1161/hc2401.092816. View

4.
Sen S, McDonald S, Coates P, Bonder C . Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond). 2010; 120(7):263-83. DOI: 10.1042/CS20100429. View

5.
Kwon O, Miller S, Li N, Khan A, Kadry Z, Uemura T . Bone marrow-derived endothelial progenitor cells and endothelial cells may contribute to endothelial repair in the kidney immediately after ischemia-reperfusion. J Histochem Cytochem. 2010; 58(8):687-94. PMC: 2907274. DOI: 10.1369/jhc.2010.956011. View